Border to Coast Pensions Partnership Ltd purchased a new stake in The Cooper Companies, Inc. (NASDAQ:COO – Free Report) during the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm purchased 379,076 shares of the medical device company’s stock, valued at approximately $27,187,000.
Other hedge funds have also added to or reduced their stakes in the company. Capital World Investors increased its position in Cooper Companies by 25.7% in the third quarter. Capital World Investors now owns 10,551,592 shares of the medical device company’s stock worth $723,417,000 after purchasing an additional 2,159,233 shares during the period. State Street Corp lifted its position in Cooper Companies by 2.4% during the 4th quarter. State Street Corp now owns 8,793,747 shares of the medical device company’s stock valued at $720,736,000 after purchasing an additional 207,195 shares during the period. Wellington Management Group LLP lifted its position in Cooper Companies by 332.9% during the 3rd quarter. Wellington Management Group LLP now owns 6,184,992 shares of the medical device company’s stock valued at $424,043,000 after purchasing an additional 4,756,178 shares during the period. Price T Rowe Associates Inc. MD boosted its stake in shares of Cooper Companies by 58.8% in the 4th quarter. Price T Rowe Associates Inc. MD now owns 6,028,821 shares of the medical device company’s stock valued at $494,123,000 after purchasing an additional 2,231,568 shares during the last quarter. Finally, Sustainable Growth Advisers LP grew its position in shares of Cooper Companies by 22.1% during the 3rd quarter. Sustainable Growth Advisers LP now owns 4,132,535 shares of the medical device company’s stock worth $283,327,000 after buying an additional 747,476 shares during the period. Institutional investors own 24.39% of the company’s stock.
Key Headlines Impacting Cooper Companies
Here are the key news stories impacting Cooper Companies this week:
- Positive Sentiment: Stifel reiterated a Buy rating on Cooper Companies while sale talks involving CooperSurgical reportedly continue, which is fueling investor optimism that the company could unlock value through a divestiture. Stifel Backs Cooper Companies (COO) as CooperSurgical Sale Talks Progress
- Positive Sentiment: Zacks Research raised multiple earnings estimates for Cooper Companies across 2026-2028, including higher forecasts for FY2026, FY2027, and FY2028. Higher earnings expectations can support the stock by suggesting stronger long-term profitability.
- Neutral Sentiment: Recent short-interest data showed 0 shares of short interest, offering little actionable signal for the stock.
Wall Street Analysts Forecast Growth
Check Out Our Latest Stock Report on COO
Cooper Companies Price Performance
Cooper Companies stock opened at $71.02 on Friday. The company has a current ratio of 1.27, a quick ratio of 0.78 and a debt-to-equity ratio of 0.23. The firm has a market capitalization of $13.85 billion, a P/E ratio of 60.19, a PEG ratio of 1.86 and a beta of 0.87. The business has a 50-day moving average of $64.10 and a 200-day moving average of $73.64. The Cooper Companies, Inc. has a 1 year low of $58.89 and a 1 year high of $89.83.
Cooper Companies (NASDAQ:COO – Get Free Report) last announced its quarterly earnings results on Thursday, June 4th. The medical device company reported $1.21 earnings per share for the quarter, beating analysts’ consensus estimates of $1.10 by $0.11. Cooper Companies had a net margin of 5.57% and a return on equity of 10.88%. The business had revenue of $1.08 billion for the quarter, compared to the consensus estimate of $1.05 billion. During the same period last year, the company posted $0.96 EPS. Cooper Companies’s revenue for the quarter was up 7.9% on a year-over-year basis. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. On average, equities analysts anticipate that The Cooper Companies, Inc. will post 4.63 EPS for the current year.
Cooper Companies Company Profile
Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.
The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.
Read More
- Five stocks we like better than Cooper Companies
- 3 Stocks That Could Benefit as the Robotaxi Race Heats Up
- 3 Waste Stocks Turning AI Investments into Growth
- 3 Overlooked Tech ETFs That Are Quietly Killing It This Year
- 3 ETFs Pairing Market-Beating Returns With High Dividend Yields
Want to see what other hedge funds are holding COO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Cooper Companies, Inc. (NASDAQ:COO – Free Report).
Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.
